Autumn wave of COVID-19 may be starting: vaccination and testing are key Infections with the coronavirus SARS-CoV-2 in the Netherlands have been increasing for the past few weeks. Hospital admissions are also on the rise.
Effect of air cleaners on COVID-19 not yet clear It is not yet clear whether air cleaners that can be moved around actually help to reduce transmission of the coronavirus SARS-CoV-2. These findings are from a literature review conducted by RIVM.
Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
Nitrate leaching on derogation farms in sandy regions continues to rise Nitrate leaching on ‘derogation farms’ has risen in recent years, most likely due to the drought experienced throughout the Netherlands in 2018 and regionally in both 2019 and 2020.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Vulnerable groups in society have been hit harder by the COVID-19 pandemic Some vulnerable groups in society have been hit harder by the COVID-19 pandemic than less vulnerable groups. These include young people (up to 24 years) who have physical or mental problems or come from low-income families.
Operations postponed due to pandemic result in 320,000 healthy life years lost The COVID-19 pandemic caused over 305,000 operations to be postponed in 2020 and 2021 in the Netherlands.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
Pressure drainage can be a cost-effective technology to reduce CO2 emissions in peatland areas Pressure drainage can in some cases help to reduce CO2 emissions in peatland areas. This intervention is very expensive and only cost-effective when it sufficiently reduces CO2 emissions.
Nearly twice as many cases involving long-term symptoms after COVID-19 Three months after infection with the coronavirus SARS-CoV-2, almost half of people still report one or more long-term symptoms, such as fatigue, difficulty concentrating and loss of smell.